Page last updated: 2024-10-18

iodine and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

iodine has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 1 studies

Iodine: A nonmetallic element of the halogen group that is represented by the atomic symbol I, atomic number 53, and atomic weight of 126.90. It is a nutritionally essential element, especially important in thyroid hormone synthesis. In solution, it has anti-infective properties and is used topically.
diiodine : Molecule comprising two covalently bonded iodine atoms with overall zero charge..

Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
OZARDA, A1
ERGIN, U1
BENDER, MA1

Other Studies

1 other study available for iodine and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

ArticleYear
Chronic myelogenous leukemia following I-131 therapy for metastatic thyroid carcinoma. Report of a case and some considerations on the etiologic factors.
    The American journal of roentgenology, radium therapy, and nuclear medicine, 1961, Volume: 85

    Topics: Carcinoma; Humans; Iodine; Iodine Radioisotopes; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL P

1961